186 related articles for article (PubMed ID: 21857663)
1. An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1.
Yoon SI; Hong M; Wilson IA
Nat Struct Mol Biol; 2011 Aug; 18(9):1028-35. PubMed ID: 21857663
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of mouse and human RP105/MD-1 complexes reveal unique dimer organization of the toll-like receptor family.
Ohto U; Miyake K; Shimizu T
J Mol Biol; 2011 Nov; 413(4):815-25. PubMed ID: 21959264
[TBL] [Abstract][Full Text] [Related]
3. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105.
Divanovic S; Trompette A; Atabani SF; Madan R; Golenbock DT; Visintin A; Finberg RW; Tarakhovsky A; Vogel SN; Belkaid Y; Kurt-Jones EA; Karp CL
Nat Immunol; 2005 Jun; 6(6):571-8. PubMed ID: 15852007
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1.
Divanovic S; Trompette A; Atabani SF; Madan R; Golenbock DT; Visintin A; Finberg RW; Tarakhovsky A; Vogel SN; Belkaid Y; Kurt-Jones EA; Karp CL
J Endotoxin Res; 2005; 11(6):363-8. PubMed ID: 16303092
[TBL] [Abstract][Full Text] [Related]
6. The radioprotective 105/MD-1 complex contributes to diet-induced obesity and adipose tissue inflammation.
Watanabe Y; Nakamura T; Ishikawa S; Fujisaka S; Usui I; Tsuneyama K; Ichihara Y; Wada T; Hirata Y; Suganami T; Izaki H; Akira S; Miyake K; Kanayama HO; Shimabukuro M; Sata M; Sasaoka T; Ogawa Y; Tobe K; Takatsu K; Nagai Y
Diabetes; 2012 May; 61(5):1199-209. PubMed ID: 22396206
[TBL] [Abstract][Full Text] [Related]
7. TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation.
Karper JC; Ewing MM; de Vries MR; de Jager SC; Peters EA; de Boer HC; van Zonneveld AJ; Kuiper J; Huizinga EG; Brondijk TH; Jukema JW; Quax PH
PLoS One; 2013; 8(7):e67923. PubMed ID: 23844130
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of mouse MD-1 with endogenous phospholipid bound in its cavity.
Harada H; Ohto U; Satow Y
J Mol Biol; 2010 Jul; 400(4):838-46. PubMed ID: 20595044
[TBL] [Abstract][Full Text] [Related]
9. The Structural Basis for Lipid and Endotoxin Binding in RP105-MD-1, and Consequences for Regulation of Host Lipopolysaccharide Sensitivity.
Ortiz-Suarez ML; Bond PJ
Structure; 2016 Jan; 24(1):200-211. PubMed ID: 26671709
[TBL] [Abstract][Full Text] [Related]
10. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1.
Miyake K; Ogata H; Nagai Y; Akashi S; Kimoto M
J Endotoxin Res; 2000; 6(5):389-91. PubMed ID: 11521060
[TBL] [Abstract][Full Text] [Related]
11. Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide.
Kimoto M; Nagasawa K; Miyake K
Scand J Infect Dis; 2003; 35(9):568-72. PubMed ID: 14620136
[TBL] [Abstract][Full Text] [Related]
12. The functional and structural properties of MD-2 required for lipopolysaccharide binding are absent in MD-1.
Tsuneyoshi N; Fukudome K; Kohara J; Tomimasu R; Gauchat JF; Nakatake H; Kimoto M
J Immunol; 2005 Jan; 174(1):340-4. PubMed ID: 15611257
[TBL] [Abstract][Full Text] [Related]
13. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide.
Nagai Y; Shimazu R; Ogata H; Akashi S; Sudo K; Yamasaki H; Hayashi S; Iwakura Y; Kimoto M; Miyake K
Blood; 2002 Mar; 99(5):1699-705. PubMed ID: 11861286
[TBL] [Abstract][Full Text] [Related]
14. The radioprotective 105/MD-1 complex links TLR2 and TLR4/MD-2 in antibody response to microbial membranes.
Nagai Y; Kobayashi T; Motoi Y; Ishiguro K; Akashi S; Saitoh S; Kusumoto Y; Kaisho T; Akira S; Matsumoto M; Takatsu K; Miyake K
J Immunol; 2005 Jun; 174(11):7043-9. PubMed ID: 15905547
[TBL] [Abstract][Full Text] [Related]
15. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.
Yazawa N; Fujimoto M; Sato S; Miyake K; Asano N; Nagai Y; Takeuchi O; Takeda K; Okochi H; Akira S; Tedder TF; Tamaki K
Blood; 2003 Aug; 102(4):1374-80. PubMed ID: 12714520
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of soluble MD-1 and its interaction with lipid IVa.
Yoon SI; Hong M; Han GW; Wilson IA
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10990-5. PubMed ID: 20534476
[TBL] [Abstract][Full Text] [Related]
17. The amino-terminal region of toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface.
Fujimoto T; Yamazaki S; Eto-Kimura A; Takeshige K; Muta T
J Biol Chem; 2004 Nov; 279(46):47431-7. PubMed ID: 15337750
[TBL] [Abstract][Full Text] [Related]
18. Involvement of RP105 and toll-like receptors in the activation of mouse peritoneal macrophages by Staphylococcus aureus.
Liu B; Fu Y; Feng S; Zhang X; Liu Z; Cao Y; Li D; Liang D; Li F; Zhang N; Yang Z
Scand J Immunol; 2013 Jul; 78(1):8-16. PubMed ID: 23521167
[TBL] [Abstract][Full Text] [Related]
19. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
Nishiya T; DeFranco AL
J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2.
da Silva Correia J; Soldau K; Christen U; Tobias PS; Ulevitch RJ
J Biol Chem; 2001 Jun; 276(24):21129-35. PubMed ID: 11274165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
